-
Scientists discover intake of FDA-approved drug modulates disease progression in Alzheimer’s model
23 Mar 2022 18:41 GMT
… recently published in Science Translational Medicine, investigates how niacin modulates … this project as the FDA-approved Niaspan drug—activates the receptor, … being used in clinical trials in Parkinson’s disease … for a clinical pilot trial to study the affects …
-
NIASPAN Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com
14 Jan 2019 13:38 GMT
… com's offering.
NIASPAN Drug Profile, 2019 is part of … -S Medication SolutionsCarilion Materials ManagementDispensing Solutions Inc.Zydus Pharmaceuticals USA … Topics:Cardiovascular Drugs
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research …
-
Niaspan LP - API Insight, 2019 with Historical & Forecasted Sales to 2021 - ResearchAndMarkets.com
05 Apr 2019 17:54 GMT
… safety, pharmacological properties, clinical trials, and product development activities … exploit opportunities for generic Niaspan LP development opportunities
… Topics:Cardiovascular Drugs
KEYWORD:
INDUSTRY KEYWORD: HEALTH CARDIOLOGY PHARMACEUTICAL
SOURCE: …
-
Adamas Pharmaceuticals' (ADMS) CEO Gregory Went on Q1 2018 Results - Earnings Call Transcript
04 May 2018 02:35 GMT
… Operator
Welcome to the Adamas Pharmaceuticals'; First Quarter 2018 … the first and only FDA approved medicine for the treatment of dyskinesia in … of the Phase 3 trials at MS walking and epilepsy … career of course with Niaspan and whether there's …
-
Cautious Optimism For Adamas Pharmaceuticals Going Into The ADS-5102 PDUFA Date
22 Aug 2017 04:11 GMT
… pills. Some experts argue that Adamas should have run their trials … 3 trial. The most likely reason that this drug doesn’ … at Kos Pharmaceuticals, Inc., where he oversaw the growth of Niaspan® ( … will be the only FDA approved treatment for this indication, we …